The Association actively funds research in 53 countries. Learn about the critical pursuits happening in these featured cities.
Leading experts convened at the AAIC® Satellite Symposium to share the latest dementia science with researchers in India and across Asia, while showcasing the important research being conducted locally.
Buenos Aires, Argentina
Buenos Aires assembled a diverse network of dementia experts and policymakers at a global symposium and launched the first South American center for data sharing among international brain imaging researchers.
Chicago is home to 30+ funded studies, multiple dementia science conferences and an international brain study to track the long-term impact of COVID-19 on the brain.
Research is happening in Botswana, with efforts focused on improving the diagnosis of dementia and developing support mechanisms for those with traumatic brain injury and their caregivers.
Houston’s 30+ funded studies and clinical trials span the field of dementia science, including the U.S. POINTER lifestyle intervention study and a potential treatment that reduces brain inflammation.
The Association’s funding of groundbreaking clinical trials, research studies and the world’s largest dementia science conference lays the foundation for significant advances in Alzheimer’s treatment and prevention.
Scientists are tackling Alzheimer’s from all angles — from trials investigating potential treatments, to longitudinal studies on preventative lifestyle interventions and everything in between.
Osaka is home to an Association-funded study to determine the causes of neurodegeneration in Alzheimer’s disease. It is also the Japanese hub for sharing neuroimaging data with the international research community.
The Alzheimer’s Association is funding studies to improve the diagnosis of dementia through local initiatives, identify new targets for Alzheimer’s therapies and more.
St. Louis, U.S.
In addition to funding more than 30 studies and clinical trials in St. Louis, the Alzheimer’s Association is helping drive international research efforts to treat or prevent rare, early onset, genetic causes of Alzheimer’s and, potentially, all forms of Alzheimer’s.
Tel Aviv, Israel
Several studies examining biomarkers and cell biology — and a clinical trial investigating the safety of a drug for people living with Alzheimer's — could lead to new treatments and strategies for prevention.
Toronto hosted the world’s largest and most influential dementia science conference in 2016 and continues to drive the field of dementia science forward with multiple research studies and novel clinical trials.
Washington, D.C., U.S.
The Alzheimer’s Association's advocacy efforts have secured a sevenfold increase in federal dementia research funding in the U.S. since 2011. The Association is also propelling research by funding several promising studies, clinical trials and global dementia science conferences in the nation’s capital.